Item
Xylitol (600015-000)
100% xylitol
Sweetener
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
Location name | Address |
---|---|
Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | No. 666 Nanhuan Road Yucheng, SD 251200 CHN |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
Product Specification Sheet | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | 20 SPEC-xylitol.pdf | 4/6/2022 | 4/5/2025 |
CoA Sample | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | 600015-000-B12202002.pdf | 2/9/2022 | 2/9/2024 |
Allergens | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Allergens.pdf | 3/24/2022 | 3/23/2024 |
Country of Origin | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Country of Origin.pdf | 2/26/2025 | 2/26/2028 |
Dietary Supplement Questionnaire | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Dietary Supplement Questionnaire.pdf | 3/24/2022 | 3/24/2023 |
FSVP Assessment Form | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | FSVP Assessment Form.pdf | 11/1/2022 | 11/1/2023 |
Halal | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Futaste-Halal-SHC-x. 6.18.2027.pdf | 6/19/2024 | 6/18/2027 |
Kosher | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Futaste-Kosher Certificate-x. 3.27.2024.pdf | 3/27/2023 | 3/27/2025 |
HACCP Process Flow Diagram | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | HACCP Plan .pdf | 4/1/2022 | 3/31/2024 |
Item Questionnaire | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Item Questionnaire.pdf | 3/24/2022 | 3/23/2025 |
Label Sample | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Label 600015.jpg | 7/14/2023 | 7/13/2024 |
Label Claims | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Label Claims.pdf | 4/6/2022 | 4/5/2024 |
Label Guidance | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Label guidance Translated.pdf | 3/1/2022 | 2/29/2024 |
National Bioengineered Food Disclosure Standard (Simplified) | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 2/26/2025 | 2/26/2028 |
Gluten | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | NotApplicable_Gluten.pdf | 1/27/2025 | 1/27/2027 |
Natural | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | NotApplicable_Natural.pdf | 1/27/2025 | 1/27/2026 |
Organic | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | NotApplicable_Organic.pdf | 1/27/2025 | 1/27/2027 |
Nutrition | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Nutrition.pdf | 3/24/2022 | 3/23/2025 |
Suitability Requirements | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Suitability Requirements.pdf | 2/26/2025 | 2/26/2028 |
Lot Code | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Fustate-Batch code statement-2182022.pdf | 2/18/2022 | 2/17/2025 |
EtO Statement | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Fustate-ETO Statement-3152022.pdf | 3/15/2022 | 3/14/2024 |
GRAS/NDI/ODI Statement | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Fustate-GRAS Statement-3252022.pdf | 3/25/2022 | 3/24/2025 |
HARPC Food Safety Plan (Item) | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Fustate-HARPC plan-April 2022.pdf | 4/1/2022 | 3/31/2025 |
Heavy Metal | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Fustate-Heavy metal test report-312022.PDF | 3/1/2022 | 2/29/2024 |
Irradiation Status Statement | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Fustate-Non-Irradiated Statement-3252022.pdf | 3/25/2022 | 3/24/2024 |
No Animal Ingredient Statement | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-Animal Test Statement-11.27.2024.pdf | 11/27/2024 | 11/27/2025 |
Animal Testing Statement | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-Animal Test Statement-1272022.pdf | 1/27/2022 | 1/27/2024 |
BSE - TSE | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-BSE TSE Statement-11.27.2024.pdf | 11/27/2024 | 11/27/2027 |
California Prop. 65 | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-California Prop 65 Statement-03.03.2023.pdf | 3/3/2023 | 3/2/2025 |
GMO | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-GMO Statement 8.2.2023.pdf | 8/2/2023 | 8/1/2025 |
Ingredient Statement | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-Ingredient Statement-03.03.2023.pdf | 3/3/2023 | 3/2/2024 |
Melamine | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-Melamine Statement-11.5.2024.pdf | 11/5/2024 | 11/5/2025 |
Pesticide | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-Pesticides Annual Test Report-3.7.2023.pdf | 3/7/2023 | 3/6/2025 |
Residual Statement | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-Residual Solvents Statement-04.20.2023.pdf | 4/20/2023 | 4/19/2024 |
Safety Data Sheet (SDS) | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-SDS-Apr 2021.pdf | 4/13/2021 | 4/12/2024 |
Shelf Life | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-Shelf Life Statement-1292021.pdf | 1/29/2022 | 1/28/2025 |
Vegan/Vegetarian Statement | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-Vegan Statement-11.27.2024.pdf | 11/27/2024 | 11/27/2026 |
WADA/NSF/NFL Statement | Rochem International Inc. - Futaste Pharmaceutical Co., Ltd. | Xylitol-Futaste-WADA Statement 8.2.2023.pdf | 8/2/2023 | 8/2/2025 |